Metropolis’ 1Q was tad below JMFe with loss of PPP revenues and network expansion costs par...
Result Synopsis Metropolis reported core business growth of 12% driven by 9% volume growth and...
We interacted with METROHL’s management, the discussion provided us insights into current c...
Result Synopsis Metropolis exhibited a marginal miss on revenues and margin as Q3 sales declin...
Growth momentum continues in non-covid business Metropolis Healthcare’s (Metropolis) rep...
Shares of the healthcare service providers are trading higher, as Union Minister of Health and Fa...
Prime Minister Narendra Modi will inaugurate the Phase-I of the Mumbai-Nagpur Samruddhi Mahamarg ...
Growth continues in non-covid business Metropolis Healthcare’s (Metropolis) reported Q2F...
Volume growth pressure persists Metropolis Healthcare (METROHL) reported Q2FY23 revenue of Rs3...
Volumes key to sustainable growth Result Synopsis Metropolis clocked an inline quarter with...
Focus shifts to 2Q Metropolis’ revenue miss dominated overall earnings miss which was pr...
Volume growth expectation intact Result Synopsis Metropolis reported healthy growth of 17% ...
Risk-reward appears favorable Result Synopsis Metropolis delivered a rather weak performanc...
The company reported standalone net profit of Rs 63.11 crore for the quarter ended March 31, 2022...
Volume revival key to growth, margins Our view Metropolis missed on revenue and margin esti...
Digitalised expansion Metropolis Q3FY22 results were below estimates. The revenue was almost i...
Slow recovery in the non-COVID business Metropolis Healthcare (Metropolis) reported Q2FY22 per...
Below is quote on Fear of new covid virus variant in India will be positive Metropolis Healt...
Focus on volume revival Our view Metropolis has highlighted strong expansion plans till FY2...
Below is quote on Metropolis Healthcare Limited by Mr. Yash Gupta, Equit...
Geared for growth Incorporated in 1980, Metropolis Healthcare is one of the leading diagnostic...
Hold Metropolis Healthcare Ltd For Target Rs.2,866 Strong growth aided by covid related tests ...
Below is quote on Which stock should investors buy this GANESH CHATURTHI? by ...
Our view: Q1 FY22 was yet another disrupted quarter due to a severe COVID wave with COVID rev...
Strong recovery with margin expansion Metropolis Healthcare (Metropolis) reported Q4FY21 perfo...
Result Highlights * Healthy end to FY21 with 29% jump in patient visits and 42% revenue growth...
Below are Quote on Metropolis reported a very good set of numbers for Q4FY21 by ...